Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Am J Cardiol. 2000 Jul 1;86(1):107-10. doi: 10.1016/s0002-9149(00)00840-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Aortic Valve Insufficiency / chemically induced*
  • Aortic Valve Insufficiency / diagnostic imaging
  • Aortic Valve Insufficiency / physiopathology
  • Appetite Depressants / administration & dosage
  • Appetite Depressants / adverse effects*
  • Blood Flow Velocity / drug effects
  • Dose-Response Relationship, Drug
  • Echocardiography, Doppler, Color
  • Electrocardiography / drug effects
  • Female
  • Fenfluramine / administration & dosage
  • Fenfluramine / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Insufficiency / chemically induced*
  • Mitral Valve Insufficiency / diagnostic imaging
  • Mitral Valve Insufficiency / physiopathology
  • Myocardial Contraction / drug effects
  • Observation
  • Observer Variation
  • Phentermine / administration & dosage
  • Phentermine / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Ventricular Function, Right / drug effects

Substances

  • Appetite Depressants
  • Serotonin Uptake Inhibitors
  • Fenfluramine
  • Phentermine